Accumulation of the amyloid-beta precursor protein in multivesicular body-like organelles

Marcel M Verbeek1, Irene Otte-Höller, Jack A M Fransen

  • 1Department of Neurology, University Medical Center Nijmegen, The Netherlands. m.verbeek@ckslkn.azn.nl

Insights

Interferon-gamma and chloroquine cause amyloid precursor protein (APP) to accumulate in cellular organelles, reducing its secretion. These findings highlight the role of multivesicular bodies in APP trafficking and processing.

Area of Science:

  • Cell Biology
  • Neuroscience
  • Protein Biochemistry

Background:

  • Amyloid-beta protein production involves proteolytic cleavage of its precursor (APP).
  • The intracellular location of APP processing is not fully understood.
  • APP processing may occur in different cellular compartments.

Purpose of the Study:

  • To investigate the effect of modulating amyloid precursor protein (APP) localization on its processing.
  • To identify the intracellular organelles involved in APP trafficking and amyloid-beta production.

Main Methods:

  • Cultured human leptomeningeal smooth muscle cells and brain pericytes were used.
  • Immunofluorescence and immunoelectron microscopy were employed to track APP localization.
  • Interferon-gamma, chloroquine, IL-1, IL-6, and TNF-alpha were used to modulate APP processing.

Main Results:

  • APP was found in intracellular vesicles, including lysosomes, under normal conditions.
  • Interferon-gamma and chloroquine induced APP accumulation in multivesicular body-like organelles.
  • These organelles were identified as part of the endocytic pathway.
  • APP secretion was reduced by interferon-gamma or chloroquine.

Conclusions:

  • Multivesicular body-like organelles serve as intermediate compartments for APP intracellular trafficking.
  • APP accumulation in these organelles correlates with reduced secretion.
  • This suggests a role for endocytic pathway organelles in regulating amyloid-beta precursor protein processing.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Intralumenal Vesicles and Multivesicular Bodies01:38

Intralumenal Vesicles and Multivesicular Bodies

Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
Protein Folding Quality Check in the RER01:29

Protein Folding Quality Check in the RER

ER is the primary site for the maturation and folding of soluble and transmembrane secretory proteins. The calnexin cycle is a specific chaperone system that folds and assesses the confirmation of N-glycosylated proteins before they can exit the ER lumen. The primary players of this quality check pipeline are the lectins, ER-resident chaperones, and a glucosyl transferase enzyme. In case the calnexin system in the lumen fails to salvage a misfolded protein, it is transported to the cytoplasm...
Oligosaccharide Assembly01:24

Oligosaccharide Assembly

Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...